Company news

Revelation Biosciences, Inc. (NASDAQ:REVB) news

Revelation Biosciences, Inc. news releases on 6ix. Latest, Sep 28, 2021: Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge…

View Revelation Biosciences, Inc. →

Press releases — page 2

Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections

September 27, 2021

← Newer